Edition:
United Kingdom

Xenon Pharmaceuticals Inc (XENE.OQ)

XENE.OQ on NASDAQ Stock Exchange Global Market

2.45USD
15 Dec 2017
Change (% chg)

$0.05 (+2.08%)
Prev Close
$2.40
Open
$2.40
Day's High
$2.45
Day's Low
$2.40
Volume
19,269
Avg. Vol
11,350
52-wk High
$9.90
52-wk Low
$2.15

Chart for

About

Xenon Pharmaceuticals Inc is a Canada-based clinical-stage biopharmaceutical company. It is engaged in discovering and developing a pipeline of differentiated therapeutics for orphan indications. Its product pipeline includes: Glybera, TV-45070, GDC-0310, XEN901 (Nav1.6 inhibitor) and XEN1101. Glybera is used for the treatment... (more)

Overall

Beta: --
Market Cap(Mil.): $54.00
Shares Outstanding(Mil.): 18.00
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 88.66 16.44
EPS (TTM): -- -- --
ROI: -- 2.36 10.62
ROE: -- 2.96 14.20

BRIEF-Xenon Pharmaceuticals reports Q3 loss per share $0.43

* Xenon Pharmaceuticals reports third quarter 2017 financial results and provides corporate update

07 Nov 2017

BRIEF-Xenon Pharma announces initiation of XEN1101 phase 1 clinical trial

* Xenon Pharmaceuticals announces initiation of XEN1101 phase 1 clinical trial

17 Oct 2017

BRIEF-Xenon Pharmaceuticals Q2 net loss per common share $0.41​

* Xenon Pharmaceuticals reports second quarter 2017 financial results and provides corporate update

03 Aug 2017

Earnings vs. Estimates